Abstract:Objective To analyze the value of dynamic contrast-enhanced MRI(DCE-MRI) parameters of Extended Tofts and Exchange model in the differential diagnosis of hepatocellular carcinoma (HCC) and hepatic metastases of colorectal cancer. Methods A retrospective analysis of 40 pathologically confirmed cases was conducted , including 25 cases of HCC and 15 cases of hepatic metastases of colorectal <br> cancer,all patients underwent DCE-MRI. Applying liver double blood supplement model , and respectively using Extended Tofts two-compartment model and Exchange model liver microvascular permeability parameters [volume transfer constant of the contrast agent(Ktrans), efflux rate from extracellular extravascular space to plasma(Kep), extravascular extracellular volume fraction(Ve)and blood plasma space volume fraction (Vp)] and the perfusion parameter hepatic arterial perfusion index(HPI) in the lesion parenchyma of HCC and metastases were calculated. We used t test to compare the differences of the parameters measured from the two types of tumors , statistically significant parameters between HCC and metastases were screened which compared with the gold standard of pathological findings in order to draw the ROC curves to evaluate the diagnostic efficacy of different model parameters, using χ2 test compared the diagnostic accuracy of optimal parameters between the two models. Results By using Extended Tofts and Exchange model , Ktrans value of HCC were (0.661 ± 0.402)/min and (0.604 ± 0.316)/min respectively, Ktrans value of hepatic metastases were (0.196±0.175)/min and (0.179±0.135)/min respectively;Vp value of HCC were (0.334±0.217) and (0.294± 0.098), Vp value of hepatic metastases were (0.089 ± 0.015) and (0.089 ± 0.022),respectively; HPI value of HCC were (0.680±0.281) and (0.769±0.245) , HPI value of hepatic metastases were (0.326±0.216), (0.373± 0.298), respectively. There were significant differences between HCC and hepatic metastases in Ktrans, Vp and HPI values in both models(P<0.05). There was not statistically significant difference between HCC and hepatic metastases in Kep, Ve values(P>0.05).Drawn ROC curves of Ktrans, Vp, HPI , the Ktrans value (area under the curve of 0.869) among Extended Tofts model parameters was selected as optimal parameter to identify HCC and hepatic metastases; the HPI value (area under the curve of 0.845) among Exchange model parameters was selected as optimal parameter to differentiate these two types of tumors.The diagnostic accordance rate of Extended Tofts model and Exchange model were 80.0%(32/40), 82.5%(33/40), respectively ; There was no significant difference between them(χ2=0.082,P=0.775). Conclusions Parameters including Ktrans, Vp, HPI of the Extended Tofts model and Exchange model in DCE-MRI perfusion can be used to identify HCC and hepatic metastases of colorectal cancer. Among these parameters, Ktrans of Extended Tofts model and HPI of Exchange model have higher diagnostic value in differentiating HCC and hepatic metastases of colorectal cancer.

Differential Diagnosis Value of Quantitative Color Mapping of the Arterial Enhancement Fraction between Hepatic Focal Nodular Hyperplasia and Hepatocellular Carcinoma

Comparison Between ACR CEUS LI-RADS and WFUMB-EFSUMB for Diagnosing Hepatocellular Carcinoma in High-Risk Patients

Value of dynamic contrast-enhanced MRI parameters of Extended Tofts and Exchange model in the differential diagnosis of hepatocellular carcinoma and hepatic metastases

Differential diagnosis between hepatic focal nodular hyperplasia and hepatocellular carcinoma with negative α-fetoprotein

The value of combination of micro‐flow imaging and color Doppler flow imaging in the detection of vascular in hepatic tumors

Comparison of Imaging Features Between Focal Nodular Hyperplasia and Hepatocellular Carcinoma on MR Diffusion Weighted Imaging

Differential Value of Computed Tomography Perfusion Imaging in Liver Nodules

Value of perfusion parameters and histogram analysis of triphasic computed tomography in pre-operative prediction of histological grade of hepatocellular carcinoma

Contrast-Enhanced Ultrasound in Combination with Color Doppler Ultrasound Can Improve the Diagnostic Performance of Focal Nodular Hyperplasia and Hepatocellular Adenoma

Feasibility of the quantitative assessment of blood perfusion in hepatocellular carcinoma by using three-dimensional contrast-enhanced ultrasound

Diagnosis of the hepatic focal nodular hyperplasia by ultrasonography and CT

Quantitative analysis of contrast-enhanced ultrasonography on hepatocellular carcinoma: Correlation with tumor differentiated grades

Diagnosis and Differential Diagnosis Between Focal Nodular Hyperplasia with Inflammatory Hepatocellular Adenoma on MRI

Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors

Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images

Gd-EOB-DTPA enhanced MRI nomogram model to differentiate hepatocellular carcinoma and focal nodular hyperplasia both showing iso- or hyperintensity in the hepatobiliary phase

Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma

Characterization of the arterial enhancement pattern of focal liver lesions by multiple arterial phase magnetic resonance imaging: comparison between hepatocellular carcinoma and focal nodular hyperplasia

Induction of cholinergic differentiation with neurite sprouting by de novo biosynthesis and expression of GD3 and b-series gangliosides in Neuro2a cells.

Value of Perfusion Parameters for Differentiating Hepatocellular Carcinoma and Liver Metastasis with Hypervascularity and a Normal Hepatic Background on Contrast-Enhanced Ultrasound Imaging

Differential diagnosis between alpha-fetoprotein-negative hepatocellular carcinoma without cirrhosis and hepatic focal nodular hyperplasia